Screening Protocol
ConditionPain
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age12-100
SponsorNational Center for Complementary and Integrative Health (NCCIH)
About this trial
This study is a screening evaluation for volunteers who are interested in participating in National Center for Complementary and Integrative Health (NCCIH) research studies about pain and related processes, such as emotion, mood, and decision-making. Screening may include review of medical history, physical exam, vital signs, questionnaires, blood and urine tests, and optional sensory testing to better understand pain and related symptoms. The purpose is to identify and characterize healthy volunteers and people with pain who may be eligible for future NCCIH research studies. This screening study does not test a treatment and has no formal hypothesis.
Eligibility criteria
Qualifiers
Stated interest in, and availability for, participating in NCCIH studies and willingness to comply with the procedures of this protocol.
At least 12 years of age
No identified acute health concerns (i.e. symptomatic uncontrolled diabetes mellitus, congestive heart failure, liver cirrhosis, ongoing cancer (excluding skin basal cell carcinoma and squamous cell carcinoma) as evidenced by screening medical history
Ability to understand and able to provide written informed consent form.
Disqualifiers
Have active medical or psychiatric health issues that create additional and substantial adverse risks related to study procedures. Medical examples are the acute complications of medical disease, such as asymptomatic hypertensive urgency, diabetic ketoacidosis, symptomatic hyperthyroidism, and unstable angina. Psychiatric examples are the acute complications of psychiatric disease, such as acute mania, paranoid delusions, or having active panic attacks.
Ongoing substance uses disorder or illicit substance use
Pregnancy
Trial design
Treatments tested in this trial
- Not listed
Trial groups
10,000 Participants
are grouped into 2 trial groupsSponsors and collaborators
Source ClinicalTrials.gov